.rll-youtube-player .play{--wpr-bg-4541377e-b9b1-42ca-a576-e68973322244: url('https://catchingnews.com/wp-content/plugins/wp-rocket/assets/img/youtube.png');}.perfmatters-lazy-youtube .play{--wpr-bg-80615aaf-60ab-4679-9252-68ad2164fc1f: url('https://catchingnews.com/wp-content/plugins/perfmatters/img/youtube.svg');}

Tag: Celldex Therapeutics stock price

Equity Investing

Celldex Therapeutics Inc. (CLDX) Announces Successful Results of Phase 1b Skin-Disorder Drug

Celldex Therapeutics Inc. (NASDAQ: CLDX) announced the results of a clinical trial of its drug that is intended to treat dermatological conditions. This week, Celldex

Catching News are non-trivial topics and publications about how you make money and properly dispose of it. We tell about business and entrepreneurship, start-ups, success stories. We also specialize in economic news.

Tag: Celldex Therapeutics stock price

Celldex Therapeutics Inc. (CLDX) Announces Successful Results of Phase 1b Skin-Disorder Drug

Popular Articles

Mars Mission Boosts Rocket Lab (RKLB) Stock Performance

Aldeyra (ALDX) Stock Climbs Substantially After Positive Clinical Trial Outcome

Surge In Above Food (ABVE) Stock After Announcing Strategic Acquisition

Important Links